Skip to content
Search

Latest Stories

Cold and cough management: Why environmental and lifestyle data matters?

Cold and cough management: Why environmental and lifestyle data matters?

Experts explain how pharmacists can leverage environmental and lifestyle data to provide more comprehensive advice to patients for effective management of cold and cough symptoms

As local GP services face increasing pressure, the role of pharmacists in managing minor ailments such as cold and cough has become more crucial than ever.


Considering environmental and lifestyle factors, such as pollution levels, pollen counts, smoking, and diet, is essential for the effective management of respiratory conditions.

In this article, experts explain how pharmacists can leverage these factors to provide more comprehensive advice to patients for managing cold and cough symptoms.

Dr Roger Henderson, GP and spokesperson for Olbas, says: “Environmental factors play a critical role in the exacerbation and management of respiratory conditions. For example, high pollution levels can aggravate cold and cough symptoms, particularly in areas where air quality can drastically fluctuate.

“By assessing real-time pollution data, pharmacists can advise patients to take precautions on days when pollution levels are high.”

Air pollution is well known to increase the risk of certain respiratory diseases.

Dr. Henderson explains that this is especially true with particulate pollen, which can penetrate the respiratory system when inhaled.

“Air pollution also makes individuals more vulnerable to infectious respiratory diseases, including colds, due to the effect of pollution on the body’s immune response,” he adds.

Moreover, the severity of hay fever is directly affected by the levels of atmospheric pollen.

Dr. Henderson believes that pharmacists, being deeply rooted in their communities, are ideally positioned to raise public awareness about the health threats posed by air pollution and pollen counts and support them in mitigating the risks.

He notes that simple advice such as pollen avoidance, the use of nasal sprays and masks, and hygiene tips can improve both outcome and patient satisfaction when given by pharmacists.

He expounds: “Patients with hay fever can be optimally advised about symptom prevention by community pharmacists if pollen level alerts are known in advance or if they suddenly spike.

“Patients with respiratory conditions such as COPD can also be given advice as to how to step up their preventive treatments if it’s known that atmospheric pollution is about to increase, along with a deterioration in air quality.”

Dr. Henderson underscores the importance of a holistic approach to patient care: “Taking a holistic approach with a patient provides the best chance of that patient obtaining the best advice to improve their health.”

He encourages pharmacists to consider a patient’s smoking history and nutritional status when managing cold and cough symptoms.

“Anyone presenting with a cough or cold should be asked about their smoking history and nutrition as they may be more likely to be at risk of minor ailments if their lifestyle or economic status means they are malnourished,” he says.

Rachel Anthony, Olbas Brand Manager, points out that with the mounting pressure on local GP services, pharmacists are relied on more than ever and are positioned to offer more personalised advice to patients in managing cough and cold symptoms.

She stresses that integrating environmental data such as pollution levels and pollen counts, along with lifestyle factors like smoking and diet, can significantly enhance the quality of care provided.

Rachel also highlights the importance of equipping pharmacies with a robust supply of trusted OTC brands, especially during peak cold and flu seasons.

“By monitoring environmental data and considering patients' lifestyle factors, pharmacists can be better equipped for an uplift in demand for cold and flu remedies,” she says.

To further enhance patient care, Rachel advocates for offering a diverse range of products and formats.

“Ensuring to offer a mix of products and formats will also ensure pharmacists meet the demand from cold and flu symptoms.

“Offering ‘on-the-go’ solutions also provides a convenient remedy for consumers, allowing them to alleviate their symptoms with ease.”

The Olbas Inhaler, for example, provides an instant, portable remedy for nasal congestion, perfect for quick relief on the move,” she adds.

Olbas products are distributed by Lanes Health, a family-owned business based in Gloucester.

Elizabeth Hughes-Gapper, Senior Brand Manager at Jakemans, also stresses that integrating environmental data such as pollution levels and pollen counts, can significantly enhance the advice pharmacists provide for managing cold and cough symptoms.

“Poor air quality and high pollen counts can exacerbate respiratory symptoms like coughing which leads to sore throats. By monitoring these factors, pharmacists can offer more personalised advice,” she notes.

Elizabeth also emphasises the importance of keeping updated on the latest innovative platforms, like Google Maps new feature which tracks air quality and pollen information. “This can help pharmacists better understand the environmental conditions affecting their patients and tailor their advice accordingly,” she says.

She encourages pharmacists to suggest preventive measures that align with current consumer trends and address common cold and cough symptoms.

Elizabeth points out that, with 80 per cent of people having experienced a cough and 72 per cent a sore throat in the past year, it’s essential to stock a variety of over-the-counter (OTC) remedies, particularly throat lozenges.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less